CrossrefInfokarte
A Standardized Plant Extract Containing a Target Compound is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation CuradermBEC5
Journal of Cancer Treatment and Research · 2015
DOI: 10.11648/j.jctr.20150302.12 ↗Abstract
Kein Abstract verfügbar.
EUVIMED